ALB and hepatorenal syndrome: Furthermore, approximately one-half of the ATTIRE trial’s standard treatment arm received albumin during hospitalization for complications such as SBP and hepatorenal syndrome because withholding albumin in such cases would be contrary to management guidelines.31